Psychodermatologic Educational Modules for Atopic Dermatitis
Patient education modules providing information on the psychological aspects of atopic dermatitis treatment and management.
Dermatitis+8
+ Dermatitis, Atopic
+ Hypersensitivity
Supportive Care Study
Summary
Study start date: June 2, 2025
Actual date on which the first participant was enrolled.This study focuses on evaluating special educational modules designed to help people with atopic dermatitis, also known as eczema, better manage their condition. The modules teach patients about the psychological and physical aspects of living with eczema. The goal is to see if these educational tools can reduce the severity of eczema symptoms and improve the overall quality of life for those affected. This is important because managing the mental and emotional challenges of skin conditions can be just as crucial as treating the physical symptoms. Participants in this study will use these educational modules, which provide information and strategies for dealing with the psychological impact of eczema. The study will observe how well these modules help in reducing the severity of eczema symptoms and improving participants' quality of life. By measuring these outcomes, the study aims to gather evidence on the effectiveness of the educational material, potentially leading to broader access to these resources for people with eczema.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.42 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 4 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: 1. New diagnosis or follow-up for previous diagnosis of Atopic Dermatitis. 2. Reliable internet access to be able to access the e-modules. 3. Able to speak English at a level required to understand the content of this study. 4. Child participants will be included in this study contingent on the consent of their guardian/caregiver(s). 5. Age range of eligible participants: Age 4 years and older. Exclusion Criteria: 1. Does not have a new diagnosis or follow-up for previous diagnosis of Atopic Dermatitis. 2. Unable to access and/or navigate e-modules with reasonable support/instruction. 3. Unable to speak English at a level required to understand the content of this study. 4. Unable to provide informed consent. 5. Less than 4 years of age.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 3 locations
Kaye Edmonton Clinic
Edmonton, CanadaStollery Children's Hospital
Edmonton, Canada